Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913471 · ClinicalTrials.gov registry record
Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
A clinical trial of Neuropathic Pain and Traumatic Spinal Cord Injury, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT00913471 is a study of Neuropathic Pain and Traumatic Spinal Cord Injury that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 120 participants, above the 98-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00913471, a study of Neuropathic Pain and Traumatic Spinal Cord Injury, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these biomarkers manifest. Our working hypothesis is that sustained alterations in specific inflammatory molecules are associated with chronic neuropathic pain following SCI, and that their plasma levels can serve as biomarkers to identify patients at risk for the development of neuropathic pain. Additionally the investigators are collecting skin tissue biopsy samples from patients following acute and chronic spinal cord injury to create vector-free human iPS cells from fibroblasts by direct delivery of reprogramming proteins.
Conditions Studied
Interventions
- OTHER blood samples
Study Locations (1)
Texas
- Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2009-06 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00913471
The ClinicalTrials.gov registry entry for NCT00913471 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (22% higher). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neuropathic Pain appearing as the primary indexed condition, and to 1 intervention - of which blood samples is the first listed.
NCT00913471 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00913471 about?
NCT00913471 is a clinical study titled "Biomarkers for Pain in Spinal Cord Injury (SCI) Patients". The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these bi...
What is the current status of trial NCT00913471?
This trial is currently active not recruiting. The enrollment target is 120 participants. The study started on 2009-06. Estimated completion is 2030-12.
What conditions does trial NCT00913471 study?
This clinical trial studies the following conditions: Neuropathic Pain, Traumatic Spinal Cord Injury.
What interventions are being tested in trial NCT00913471?
The interventions under investigation include: blood samples (OTHER).
Who is sponsoring clinical trial NCT00913471?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00913471 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
RECRUITING · Phase 4
-
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
RECRUITING · Phase 1
-
Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study
RECRUITING
-
Diabetic Neuropathy in Spinal Cord Stimulator Patients
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.